Cadila Healthcare spurts as its arm receives ANDA approval for Dextroamphetamine IR Tabs

31 Mar 2016 Evaluate

Cadila Healthcare is currently trading at Rs 320.15, up by 0.60 points or 0.19% from its previous closing of Rs 319.55 on the BSE.

The scrip opened at Rs. 323.90 and has touched a high and low of Rs. 324.00 and Rs. 319.35 respectively. So far 16357 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 454.40 on 23-Oct-2015 and a 52 week low of Rs. 295.50 on 18-Jan-2016.

Last one week high and low of the scrip stood at Rs. 324.50 and Rs. 308.20 respectively. The current market cap of the company is Rs. 32754.64 crore.

The promoters holding in the company stood at 74.79%, while Institutions and Non-Institutions held 14.35% and 10.86% respectively.

Cadila Healthcare’s Nether Pharmaceuticals has received its first ANDA approval from the USFDA to market Dextroamphetamine IR Tabs. Nether Pharmaceuticals is a subsidiary of Zydus Pharmaceuticals USA. The drug falls in the CNS stimulant segment and is the first product to be developed by the R&D team at Nesher. The drug will be produced at the manufacturing facility based at St. Louis, Missouri, USA. The estimated sale for Dextroamphetamine IR Tabs is $40.6 mn as per IMS.

Nesher has considerable expertise in niche therapies which have development or production barriers, such as controlled release medications or DEA-controlled substances, which otherwise cannot be imported.

Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies. It is the only Indian pharma company to launch its own patented NCE - Lipaglyn, the world’s first drug to be approved for the treatment of diabetic dyslipidemia.

Zydus Lifesciences Share Price

881.10 13.30 (1.53%)
19-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.55
Dr. Reddys Lab 1166.45
Cipla 1391.20
Zydus Lifesciences 881.10
Lupin 2178.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×